These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 3008845)

  • 1. The effects of salts and amino group modification on the iron binding domains of transferrin.
    Thompson CP; McCarty BM; Chasteen ND
    Biochim Biophys Acta; 1986 Apr; 870(3):530-7. PubMed ID: 3008845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Salt effects on the physical properties of the transferrins.
    Chasteen ND; Grady JK; Woodworth RC; Mason AB
    Adv Exp Med Biol; 1994; 357():45-52. PubMed ID: 7762445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of salt and site-directed mutations on the iron(III)-binding site of human serum transferrin as probed by EPR spectroscopy.
    Grady JK; Mason AB; Woodworth RC; Chasteen ND
    Biochem J; 1995 Jul; 309 ( Pt 2)(Pt 2):403-10. PubMed ID: 7626003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electron paramagnetic resonance measurement of the distance between the metal binding sites of transferrin.
    Zweier JL
    J Biol Chem; 1983 Nov; 258(22):13759-60. PubMed ID: 6315709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Large cooperativity in the removal of iron from transferrin at physiological temperature and chloride ion concentration.
    Hamilton DH; Turcot I; Stintzi A; Raymond KN
    J Biol Inorg Chem; 2004 Dec; 9(8):936-44. PubMed ID: 15517438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutational analysis of C-lobe ligands of human serum transferrin: insights into the mechanism of iron release.
    Mason AB; Halbrooks PJ; James NG; Connolly SA; Larouche JR; Smith VC; MacGillivray RT; Chasteen ND
    Biochemistry; 2005 Jun; 44(22):8013-21. PubMed ID: 15924420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonequivalence of the metal binding sites in vanadyl-labeled human serum transferrin.
    Cannon JC; Chasteen ND
    Biochemistry; 1975 Oct; 14(21):4573-7. PubMed ID: 241383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Iron removal from monoferric human serum transferrins by 1, 2-dimethyl-3-hydroxypyridin-4-one, 1-hydroxypyridin-2-one and acetohydroxamic acid.
    Li Y; Harris WR
    Biochim Biophys Acta; 1998 Sep; 1387(1-2):89-102. PubMed ID: 9748517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Release of iron from the two iron-binding sites of transferrin by cultured human cells: modulation by methylamine.
    Bomford A; Young SP; Williams R
    Biochemistry; 1985 Jul; 24(14):3472-8. PubMed ID: 3862428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The exchange of Fe3+ between pyrophosphate and transferrin. Probing the nature of an intermediate complex with stopped flow kinetics, rapid multimixing, and electron paramagnetic resonance spectroscopy.
    Cowart RE; Swope S; Loh TT; Chasteen ND; Bates GW
    J Biol Chem; 1986 Apr; 261(10):4607-14. PubMed ID: 3007467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Copper binding selectivity of N- and C-sites in serum (human)- and ovo-transferrin.
    Hirose J; Fujiwara H; Magarifuchi T; Iguti Y; Iwamoto H; Kominami S; Hiromi K
    Biochim Biophys Acta; 1996 Aug; 1296(1):103-11. PubMed ID: 8765235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of the synergistic anion on electron paramagnetic resonance spectra of iron-transferrin anion complexes is consistent with bidentate binding of the anion.
    Dubach J; Gaffney BJ; More K; Eaton GR; Eaton SS
    Biophys J; 1991 May; 59(5):1091-100. PubMed ID: 1651123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of salt concentration on the iron-binding properties of human transferrin.
    Williams J; Chasteen ND; Moreton K
    Biochem J; 1982 Mar; 201(3):527-32. PubMed ID: 7092809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of the iron saturation of transferrin on its binding and uptake by rabbit reticulocytes.
    Young SP; Bomford A; Williams R
    Biochem J; 1984 Apr; 219(2):505-10. PubMed ID: 6743230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uptake and release of iron from human transferrin.
    Huebers H; Josephson B; Huebers E; Csiba E; Finch C
    Proc Natl Acad Sci U S A; 1981 Apr; 78(4):2572-6. PubMed ID: 6941310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of pH on the equilibrium distribution of iron between the metal-binding sites of human transferrin.
    Chasteen ND; Williams J
    Biochem J; 1981 Mar; 193(3):717-27. PubMed ID: 7305958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinetic studies on the removal of iron and aluminum from recombinant and site-directed mutant N-lobe half transferrins.
    Li Y; Harris WR; Maxwell A; MacGillivray RT; Brown T
    Biochemistry; 1998 Oct; 37(40):14157-66. PubMed ID: 9760252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spectroscopic and thermodynamic studies on the binding of gadolinium(III) to human serum transferrin.
    Zak O; Aisen P
    Biochemistry; 1988 Feb; 27(3):1075-80. PubMed ID: 2835077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mössbauer studies of electrophoretically purified monoferric and diferric human transferrin.
    Kretchmar SA; Teixeira M; Huynh BH; Raymond KN
    Biol Met; 1988; 1(1):26-32. PubMed ID: 3152869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Release of iron from diferric transferrin in the presence of rat liver plasma membranes: no evidence of a plasma membrane diferric transferrin reductase.
    Thorstensen K; Aisen P
    Biochim Biophys Acta; 1990 Apr; 1052(1):29-35. PubMed ID: 2157501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.